Literature DB >> 11372007

Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy.

U Elkayam1, P P Tummala, K Rao, M W Akhter, I S Karaalp, O R Wani, A Hameed, I Gviazda, A Shotan.   

Abstract

BACKGROUND: Peripartum cardiomyopathy is a rare and sometimes fatal form of heart failure. Little is known about the outcomes of subsequent pregnancies in women who have had the disorder.
METHODS: Through a survey of members of the American College of Cardiology, we identified 44 women who had had peripartum cardiomyopathy and had a total of 60 subsequent pregnancies. We then reviewed the medical records of these women and interviewed the women or their physicians.
RESULTS: Among the first subsequent pregnancies in the 44 women, 28 occurred in women in whom left ventricular function had returned to normal (group 1) and 16 occurred in women with persistent left ventricular dysfunction (group 2). The pregnancies were associated with a reduction in the mean (+/-SD) left ventricular ejection fraction both in the total cohort (from 49+/-12 percent to 42+/-13 percent, P<0.001) and in each group separately (from 56+/-7 percent to 49+/-10 percent in group 1, P=0.002; and from 36+/-9 percent to 32+/-11 percent in group 2, P=0.08). During these pregnancies, a decrease of more than 20 percent in the left ventricular ejection fraction occurred in 21 percent of the women in group 1 and 25 percent of those in group 2, and symptoms of heart failure occurred in 21 percent of the women in group 1 and 44 percent of those in group 2. The mortality rate was 0 percent in group 1 and 19 percent in group 2 (P=0.06). In addition, the frequency of premature delivery was higher in group 2 (37 percent vs. 11 percent), as was that of therapeutic abortions (25 percent vs. 4 percent).
CONCLUSIONS: Subsequent pregnancy in women with a history of peripartum cardiomyopathy is associated with a significant decrease in left ventricular function and can result in clinical deterioration and even death.

Entities:  

Mesh:

Year:  2001        PMID: 11372007     DOI: 10.1056/NEJM200105243442101

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  65 in total

1.  Title tattles.

Authors:  K Flegel
Journal:  CMAJ       Date:  2001-12-11       Impact factor: 8.262

2.  Why do some recovered peripartum cardiomyopathy mothers experience heart failure with a subsequent pregnancy?

Authors:  James D Fett; Tina P Shah; Dennis M McNamara
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-01

Review 3.  Heart failure in women.

Authors:  J Julia Shin; Eman Hamad; Sandhya Murthy; Ileana L Piña
Journal:  Clin Cardiol       Date:  2012-03       Impact factor: 2.882

4.  Cardiac disease in pregnancy: value of echocardiography.

Authors:  Sarah Tsiaras; Athena Poppas
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

Review 5.  Pathophysiology and epidemiology of peripartum cardiomyopathy.

Authors:  Denise Hilfiker-Kleiner; Karen Sliwa
Journal:  Nat Rev Cardiol       Date:  2014-04-01       Impact factor: 32.419

6.  [Heart diseases in pregnancy].

Authors:  Vera Regitz-Zagrosek; Christa Gohlke-Bärwolf; Annette Geibel-Zehender; Markus Haass; Harald Kaemmerer; Irmtraut Kruck; Christoph Nienaber
Journal:  Clin Res Cardiol       Date:  2008-09       Impact factor: 5.460

Review 7.  Does the immune system induce labor? Lessons from preterm deliveries in women with autoimmune diseases.

Authors:  Norbert Gleicher
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

8.  Emergent caesarean section under mechanical circulatory support for acute severe peripartum cardiomyopathy.

Authors:  Takeshi Mikami; Hitoshi Kamiunten
Journal:  J Cardiol Cases       Date:  2018-03-21

9.  Peripartum cardiomyopathy: an intriguing challenge. Case report with literature review.

Authors:  Roberto Cemin; Rajesh Janardhanan; Massimo Daves
Journal:  Curr Cardiol Rev       Date:  2009-11

Review 10.  Peripartum cardiomyopathy: review of the literature.

Authors:  Pradipta Bhakta; Binay K Biswas; Basudeb Banerjee
Journal:  Yonsei Med J       Date:  2007-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.